The FOXO3 transcription factor has been shown to mediate the cytotoxic effects of chemotherapeutic agents in breast cancer through promoting the expression of downstream transcriptional targets involved in proliferative arrest and cell death9. Here, FOXO3 is linked to breast carcinoma.